Houston, Texas and Tuebingen, Germany, April 21, 2026 - Immatics N.V. (NASDAQ: IMTX, "Immatics" or the "Company"), the global leader in precision targeting of PRAME with multiple clinical-stage progra ...
1hOpinion
AI Slop Is A Leadership Problem
Generative AI needs clear standards and accountability. As the OECD has repeatedly highlighted, AI is transformative but, ...
Oral presentation will include previously announced topline results as well as pre-specified and post-hoc data updatesREDWOOD CITY, Calif., April ...
Digital leadership is not about technology, but about improving care, writes Ian McKenzie, CIO at Surrey and Borders Partnership NHS FT ...
The perfect custom picture frame enhances the artwork, protects it from environmental damage, and ensures it complements your ...
Performance Studies BA candidate Vela Zhu recently presented at the NYU Center for Research & Study Graduate Conference, ...
An exhibition explores examples of Pop Art from the 1960s in dialogue with recent acquisitions by contemporary artists.
Lu-RAD202 demonstrated encouraging tumor uptake and a favorable safety profile in the lowest dose cohort Data Safety and Monitoring Committee ...
Infused with poetry and élan, installations and designs that appeal to the growing number of discerning global collectors of ...
The 46th annual 5th Avenue Arts Festival will take place April 25-26. Ani DiFranco will perform at Heartwood Soundstage at 7 ...
Morning Overview on MSN
New bowel cancer approach keeps disease at bay for 3 years
Every patient enrolled in a groundbreaking rectal cancer trial has remained disease-free for more than three years after ...
Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating Fast Track designated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results